Přejít k obsahu
Merck

Transcriptional regulation of N6-methyladenosine orchestrates sex-dimorphic metabolic traits.

Nature metabolism (2021-07-21)
David A Salisbury, David Casero, Zhengyi Zhang, Dan Wang, Jason Kim, Xiaohui Wu, Laurent Vergnes, Aashiq H Mirza, Paola Leon-Mimila, Kevin J Williams, Adriana Huertas-Vazquez, Samie R Jaffrey, Karen Reue, Jianjun Chen, Tamer Sallam
ANOTACE

Males and females exhibit striking differences in the prevalence of metabolic traits including hepatic steatosis, a key driver of cardiometabolic morbidity and mortality. RNA methylation is a widespread regulatory mechanism of transcript turnover. Here, we show that presence of the RNA modification N6-methyladenosine (m6A) triages lipogenic transcripts for degradation and guards against hepatic triglyceride accumulation. In male but not female mice, this protective checkpoint stalls under lipid-rich conditions. Loss of m6A control in male livers increases hepatic triglyceride stores, leading to a more 'feminized' hepatic lipid composition. Crucially, liver-specific deletion of the m6A complex protein Mettl14 from male and female mice significantly diminishes sex-specific differences in steatosis. We further surmise that the m6A installing machinery is subject to transcriptional control by the sex-responsive BCL6-STAT5 axis in response to dietary conditions. These data show that m6A is essential for precise and synchronized control of lipogenic enzyme activity and provide insights into the molecular basis for the existence of sex-specific differences in hepatic lipid traits.

MATERIÁLY
Číslo produktu
Značka
Popis produktu

Sigma-Aldrich
Monoclonal Anti-DCP1A antibody produced in mouse, clone 3G4, purified immunoglobulin, buffered aqueous solution